Betta Pharmaceuticals (SHE:300558) resubmitted its application to offer and list shares on the Hong Kong Stock Exchange on Aug. 28, according to a Monday disclosure on the Shenzhen bourse.
The Chinese pharmaceutical company's shares fell 2% during the afternoon trade.